Clovis Oncology, Inc. (CLVS) Social Stream



Clovis Oncology, Inc. (CLVS): $4.33

-0.05 (-1.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLVS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 509

in industry

Clovis Oncology Inc (CLVS) Price Targets From Analysts

Use the tables below to see what analysts covering Clovis Oncology Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $10 $3 $5.9 $4.45 32.58%

The Trend in the Analyst Price Target


CLVS's average price target has moved down $1.43 over the prior 29 weeks.

Over the past 15 months, CLVS's average upside potential has been 26.06%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-19 5 10 3 5.90 4.06 45.32%
2021-08-14 5 10 3 5.90 4.78 23.43%
2021-08-07 5 10 3 5.90 4.97 18.71%
2021-08-05 5 12 3 6.30 5.06 24.51%
2021-07-26 5 12 3 6.35 4.76 33.4%
2021-06-28 5 12 3 6.35 6.17 2.92%
2021-06-26 5 12 3 6.35 6.54 -2.91%
2021-06-13 5 12 3 6.35 5.78 9.86%
2021-05-03 6 13 3 7.13 5.77 23.57%
2021-04-25 6 13 3 7.13 6.09 17.08%
2021-04-01 6 13 3 7.13 6.99 2%
2021-03-20 6 13 3 7.13 7.86 -9.29%
2021-03-13 6 13 3 7.13 5.94 20.03%
2021-02-01 6 15 3 7.33 8.46 -13.36%
2021-01-30 6 15 3 7.33 7.90 -7.22%
2021-01-23 6 15 3 7.33 6.68 9.73%
2021-01-16 6 15 3 7.33 5.58 31.36%
2021-01-09 6 15 3 7.33 5.05 45.15%
2021-01-02 6 15 3 7.33 4.80 52.71%
2020-12-26 6 15 3 7.33 4.88 50.2%
2020-12-19 6 15 3 7.33 4.90 49.59%
2020-11-23 6 15 3 7.33 4.18 75.36%
2020-11-05 6 15 3 7.00 4.47 56.6%
2020-10-28 6 23 4 8.67 5.20 66.73%
2020-08-27 6 23 4 8.67 NA NA%
2020-08-14 7 23 4 9.71 NA NA%
2020-08-13 7 23 4 9.57 NA NA%
2020-08-07 8 32 4 12.38 NA NA%
2020-07-21 8 32 4 13.62 NA NA%
2020-05-21 8 32 4 13.62 NA NA%

CLVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.17 0 1 2 0 0 6

The Trend in the Broker Recommendations


Over the past 17 months, CLVS's average broker recommendation rating worsened by 0.55.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Clovis Oncology Inc's variance in analysts' estimates is lower than 2.75% of all US stocks.
  • Clovis Oncology Inc's average analyst price target is greater than 4.82% of stocks in the mid market cap category.
  • The upside potential (average analyst target price relative to current price) of CLVS is higher than 19.05% of Pharmaceutical Products stocks.
  • Clovis Oncology Inc's number of analysts covering the stock is higher than 30.43% of stocks in the mid market cap category.

Stocks similar to Clovis Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APRE, LHDX and LMNL.

Is CLVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8815 seconds.